Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver.
Hepatic encephalopathy may occur following acute hepatic failure (AHF), which results in the release of toxic compounds from the injured liver. These compounds, which induce cerebral edema, are not well characterized, yet. The aim of this study was to evaluate the potential interest of NMR spectroscopy in the follow-up of different plasma compounds in pigs with ischemia-induced fulminant hepatic failure treated or not with a bioartificial liver (BAL), which has been previously shown to improve the neurological status of the animals. Qualitative analysis of pig plasma was achieved by one-dimensional-(1)H CPMG, two-dimensional homonuclear (1)H-(1)H TOCSY CPMG and heteronuclear (1)H-(13)C HSQC sequences. Semi-quantitative analysis of selected plasma metabolites along the disease evolution was carried out on pigs with ischemia-induced AHF treated with the BAL containing alginate beads with or without hepatocytes. A quantitative longitudinal follow-up was performed on characteristic metabolites via a one-dimensional CPMG sequence, including choline, glutamine, N-acetyl-glucosamine (NAG), pyruvate and trimethylamine-N-oxide (TMAO). The concentrations of choline and TMAO increased from the beginning to the end in animals treated with the BAL containing alginate beads without hepatocytes. Treatment of pigs with BAL containing hepatocytes resulted in an improvement of survival, the plasma concentrations of choline and TMAO being decreased in three out of five animals. Thus, NMR spectroscopy is a useful approach for the identification of toxic compounds which are involved in hepatic encephalopathy associated with AHF. These compounds can be cleared by a BAL resulting in the improvement of survival and neurological parameters of the animals.
D000208:Acute Disease; D000596:Amino Acids / Q000097:blood; D000818:Animals; D002241:Carbohydrates / Q000097:blood; D004195:Disease Models, Animal; D006501:Hepatic Encephalopathy / Q000097:blood* / Q000209:etiology / Q000601:surgery*; D022781:Hepatocytes / Q000378:metabolism / Q000473:pathology; D007511:Ischemia / Q000097:blood / Q000150:complications*; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000098:blood supply*; D008102:Liver Circulation; D019164:Liver, Artificial; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D013552:Swine
D000596:Amino Acids; D002241:Carbohydrates; D008074:Lipoproteins